New York Blood Center Enterprises and Human Life CORD Sign Letter of Intent to Expand Manufacturing Collaboration for Umbilical Cord -Derived Mesenchymal Stromal Cells

New York Blood Center Enterprises (NYBCe) and Human Life CORD Japan Inc. have signed a Letter of Intent to expand their manufacturing collaboration for MSCs. This partnership aims to enhance the global supply chain for next-generation umbilical cord tissue-derived MSCs.